Navigation Links
KaloBios to Present at Leerink Swann Rare Disease Roundtable
Date:9/30/2013

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals (Nasdaq: KBIO) today announced that the company will present at the Leerink Swann Rare Disease Roundtable on October 2 at the Le Parker Meridien in New York City. KaloBios President and Chief Executive Officer, David W. Pritchard, will provide an overview of KaloBios and the company's three current clinical programs for its proprietary, patient-targeted monoclonal antibody therapeutics.

(Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO)

Company Presentation:
When: Wednesday, October 2, 2013, 10:30 AM EDT
Where: Le Parker Meridien, New York City, NY

Webcast:
To access the live and archived audio webcast of this presentation please log on through a link located in the Investors section of the KaloBios Pharmaceuticals website under the Events & Presentations tab: http://leerink.metameetings.com/webcasts/rdroundtable13/directlink?ticker=KBIO.

A replay of the webcast will be available one hour after the conclusion of the live event. 

About KaloBios
KaloBios Pharmaceuticals, Inc. is developing a portfolio of patient-targeted, first-in-class monoclonal antibodies to treat severe medical conditions with a primary clinical focus on respiratory diseases and cancer.  For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

Contact:

Jeffrey H. Cooper
Chief Financial Officer
KaloBios Pharmaceuticals, Inc.
(650) 243-3146
ir@kalobios.com

Media Contact:

Joan E. Kureczka
Kureczka/Martin Associates 
Tel:  (415) 821-2413
Mobile: (415) 690-0210
Joan@Kureczka-Martin.com


'/>"/>
SOURCE KaloBios Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
8. KaloBios to Present at Needham Healthcare Conference
9. KaloBios Reports First Quarter 2013 Financial Results
10. KaloBios to Present at Stifel Healthcare Conference 2013
11. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... , ... PRP Science , Florida’s leading medical distribution company known for ... most respected manufacturers in the medical aesthetics arena; Ameia Med and ... developer of the EXCEED micro-needling device (MN). Recognized as the most ...
(Date:11/11/2019)... ... 11, 2019 , ... Over 60 schools in the northwest panhandle of Florida ... is designed to provide virtual mental health care to more than 35,000 students still ... October of 2018 [1]. , “This initiative by the state of Florida,” says Choice ...
(Date:11/11/2019)... ... 2019 , ... The Advocator Group, LLC, part of Brown & Brown Inc., ... published in the Boston Globe Magazine. This recognition has been earned for the fourth ... since 2014. , The rankings for the Top 100 Women-Led Businesses in each ...
Breaking Medicine Technology:
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... (VA) Maryland Health Care System reminds community members, businesses and organizations about the ... is a global movement that inspires hundreds of millions of people to give, ...
(Date:11/14/2019)... , ... November 14, 2019 , ... ... of HREI magazine’s annual, national awards program. The three projects include an adaptive ... Qualified Health Center in El Centro, Calif. that provides medical care to an ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... has been named to the CNBC Upstart 100, an exclusive list ... household names. Proscia was selected from hundreds of nominees globally for its work ...
(Date:11/11/2019)... ... ... Early praise for A Nurse’s Step-by-Step Guide to Publishing a Dissertation or DNP Project: ... and vital guidance for publishing dissertations or DNP projects. A Nurse’s Step-by-Step Guide to ... and will be shared with new graduates and colleagues alike.” , -Nancy White ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... accessible primary care and occupational medicine, is expanding its long-term partnership with ... and engage franchise candidates. With more than 200 locations across the country, American ...
Breaking Medicine News(10 mins):